Study Links First 90 Days of Antipsychotic Treatment to Rapid Metabolic Changes

A new observational study published in The Lancet Psychiatry, funded by the National Institute for Health and Care Research (NIHR) and led by University College London (UCL) researchers, indicates that the initial 90 days of antipsychotic treatment are a critical period for monitoring blood glucose and weight. The study found that glycated haemoglobin (HbA1c) and weight rose significantly faster during this period compared to before treatment.